Delivery Order SPE2DB22D2206-SPE2DB25FHL38
Award Date
6/13/25
Potential Completion Date
6/16/25
Potential Value
$6.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $13,939.20 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty medication, with a completion date of July 10, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This is a $4,316.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty pharmaceutical product, with a period of performance through March 4, 2025. The award was not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a $5,651.45 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
This is a $2,877.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of April 8, 2025 and was awarded on April 7, 2025. AmerisourceBergen holds a significant $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,884.86, is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract...
This is a $4,127.16 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty medication, with a period of performance through November 8, 2024. This delivery order is issued under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a $53,653.05 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is to provide ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty pharmaceutical product, with a period of performance through November 2024. This award is issued under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,451.48, is for the delivery of ACTEMRA 162 MG/0.9 ML syringes. The contract has an ultimate completion date of June 13, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $10,829.11 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp for the supply of ACTEMRA 162 MG/0.9 ML syringes. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $1,973.16, is for the delivery of ACTEMRA 162 MG/0.9 ML syringes to support military treatment programs and facilities. The contract has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with...